Showing results (471-480 of 871) with videos related to
Sort By:
Pageof 88
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|May 17, 2023
On the Importance of Nanoparticle Necks and Carbon Impurities for Charge Trapping in TiO2Michael J Elser, Ellie Neige, Thomas Berger, et al.Journal of Neurology|March 2, 2023
Effects of horizontal versus vertical switching of disease-modifying treatment after platform drugs on disease activity in patients with relapsing-remitting multiple sclerosis in AustriaMichael Guger, Christian Enzinger, Fritz Leutmezer, et al.Trials|October 24, 2022
Smartphone-assisted guided self-help cognitive behavioral therapy for young people with distressing voices (SmartVoices): study protocol for a randomized controlled trialMarialuisa Cavelti, Janko M Kaeser, Stefan Lerch, et al.JMIR Research Protocols|August 26, 2021
An Ecological Monitoring and Management App (EMMA) for Older Adults With Chronic Pain: Protocol for a Design and Feasibility StudyKatharina Ledermann, Omar Abou Khaled, Maurizio Caon, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 24, 2010
Impact of oxygen uptake efficiency slope as a marker of cardiorespiratory reserve on response to cardiac resynchronization therapyThomas Berger, Ralf Harun Zwick, Markus Stuehlinger, et al.Journal of Neurology|April 23, 2021
Long-term outcome and predictors of long-term disease activity in natalizumab-treated patients with multiple sclerosis: real life data from the Austrian MS Treatment RegistryMichael Guger, Christian Enzinger, Fritz Leutmezer, et al.European Journal of Neurology|July 5, 2025
De-Escalation Treatment Strategies From Natalizumab in Patients With Relapsing Multiple Sclerosis in AustriaMichael Guger, Christian Enzinger, Bettina Heschl, et al.Psychiatry Research|August 25, 2024
Longitudinal associations between beta-endorphin, nonsuicidal self-injury and comorbid psychopathologyHan-Tin Kao, Ines Mürner-Lavanchy, Stefan Lerch, et al.Neurology(R) Neuroimmunology & Neuroinflammation|April 25, 2025
SARS-CoV-2 Vaccines and Multiple Sclerosis: An UpdateTobias Monschein, Tobias Zrzavy, Paulus S Rommer, et al.Frontiers in Immunology|July 5, 2021
Cerebrospinal Fluid Findings in 541 Patients With Clinically Isolated Syndrome and Multiple Sclerosis: A Monocentric StudyKlaus Berek, Gabriel Bsteh, Michael Auer, et al.Pageof 88